Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Norio Sugawara,1–3 Norio Yasui-Furukori,2,3 Manabu Yamazaki,4 Kazutaka Shimoda,3,5 Takao Mori,4 Takuro Sugai,3,6 Hiroshi Matsuda,4 Yutaro Suzuki,3,6 Yoshitake Minami,4 Yuji Ozeki,3,5 Kurefu Okamoto,4 Toyoaki Sagae,7 Toshiyuki Someya3,6 1Aomori Prefectural Center for Mental Health and Welf...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	metabolic syndrome schizophrenia attitude Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/b06bc01b788d4341b317ed94c57eec5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b06bc01b788d4341b317ed94c57eec5c
record_format	dspace
spelling	oai:doaj.org-article:b06bc01b788d4341b317ed94c57eec5c2021-12-02T04:38:19ZAttitudes toward metabolic adverse events among patients with schizophrenia in Japan1178-2021https://doaj.org/article/b06bc01b788d4341b317ed94c57eec5c2016-02-01T00:00:00Zhttps://www.dovepress.com/attitudes-toward-metabolic-adverse-events-among-patients-with-schizoph-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Norio Sugawara,1–3 Norio Yasui-Furukori,2,3 Manabu Yamazaki,4 Kazutaka Shimoda,3,5 Takao Mori,4 Takuro Sugai,3,6 Hiroshi Matsuda,4 Yutaro Suzuki,3,6 Yoshitake Minami,4 Yuji Ozeki,3,5 Kurefu Okamoto,4 Toyoaki Sagae,7 Toshiyuki Someya3,6 1Aomori Prefectural Center for Mental Health and Welfare, Aomori, 2Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, 3Japanese Society of Clinical Neuropsychopharmacology, 4Japan Psychiatric Hospital Association, Tokyo, 5Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, 6Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 7Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences, Yonezawa, Japan Background: Metabolic syndrome is a growing concern among patients with schizophrenia because metabolic abnormalities are widely regarded as a major risk factor for cardiovascular disease and premature death. The current study assessed attitudes toward metabolic adverse events among patients with schizophrenia. Methods: A brief questionnaire was constructed to investigate patient recognition of the following broad areas: dietary habits, lifestyle, self-monitoring, knowledge, and medical practice. Between January 2012 and June 2013, questionnaires were sent to patients associated with 520 outpatient facilities and 247 inpatient facilities belonging to the Japan Psychiatric Hospital Association. All of the participants (n=22,072; inpatients =15,170, outpatients =6,902) were diagnosed with schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, or the International Classification of Diseases, tenth revision. Results: Approximately 55.0% (8,069/14,669) of inpatients and 44.8% of outpatients (2,978/6,649) reported that they did not exercise at all. Although 60.9% (4,116/6,760) of outpatients reported that they felt obese, only 35.6% (5,261/14,794) of inpatients felt obese. More than half of the inpatients (51.2%; 7,514/14,690) and outpatients (60.8%; 4,086/6,721) hoped to receive regular blood tests to prevent weight gain and diseases such as diabetes. Conclusion: Although more than half of patients hoped to prevent weight gain and diabetes, only a minority of patients were mindful of eating balanced meals and having physical exercise. Educational efforts and the promotion of the best pharmacotherapy and monitoring practices are needed for patients with schizophrenia. Keywords: metabolic syndrome, schizophrenia, attitude, JapanSugawara NYasui-Furukori NYamazaki MShimoda KMori TSugai TMatsuda HSuzuki YMinami YOzeki YOkamoto KSagae TSomeya TDove Medical Pressarticlemetabolic syndromeschizophreniaattitudeJapanNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 427-436 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	metabolic syndrome schizophrenia attitude Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	metabolic syndrome schizophrenia attitude Japan Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Sugawara N Yasui-Furukori N Yamazaki M Shimoda K Mori T Sugai T Matsuda H Suzuki Y Minami Y Ozeki Y Okamoto K Sagae T Someya T Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
description	Norio Sugawara,1–3 Norio Yasui-Furukori,2,3 Manabu Yamazaki,4 Kazutaka Shimoda,3,5 Takao Mori,4 Takuro Sugai,3,6 Hiroshi Matsuda,4 Yutaro Suzuki,3,6 Yoshitake Minami,4 Yuji Ozeki,3,5 Kurefu Okamoto,4 Toyoaki Sagae,7 Toshiyuki Someya3,6 1Aomori Prefectural Center for Mental Health and Welfare, Aomori, 2Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, 3Japanese Society of Clinical Neuropsychopharmacology, 4Japan Psychiatric Hospital Association, Tokyo, 5Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, 6Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 7Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences, Yonezawa, Japan Background: Metabolic syndrome is a growing concern among patients with schizophrenia because metabolic abnormalities are widely regarded as a major risk factor for cardiovascular disease and premature death. The current study assessed attitudes toward metabolic adverse events among patients with schizophrenia. Methods: A brief questionnaire was constructed to investigate patient recognition of the following broad areas: dietary habits, lifestyle, self-monitoring, knowledge, and medical practice. Between January 2012 and June 2013, questionnaires were sent to patients associated with 520 outpatient facilities and 247 inpatient facilities belonging to the Japan Psychiatric Hospital Association. All of the participants (n=22,072; inpatients =15,170, outpatients =6,902) were diagnosed with schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, or the International Classification of Diseases, tenth revision. Results: Approximately 55.0% (8,069/14,669) of inpatients and 44.8% of outpatients (2,978/6,649) reported that they did not exercise at all. Although 60.9% (4,116/6,760) of outpatients reported that they felt obese, only 35.6% (5,261/14,794) of inpatients felt obese. More than half of the inpatients (51.2%; 7,514/14,690) and outpatients (60.8%; 4,086/6,721) hoped to receive regular blood tests to prevent weight gain and diseases such as diabetes. Conclusion: Although more than half of patients hoped to prevent weight gain and diabetes, only a minority of patients were mindful of eating balanced meals and having physical exercise. Educational efforts and the promotion of the best pharmacotherapy and monitoring practices are needed for patients with schizophrenia. Keywords: metabolic syndrome, schizophrenia, attitude, Japan
format	article
author	Sugawara N Yasui-Furukori N Yamazaki M Shimoda K Mori T Sugai T Matsuda H Suzuki Y Minami Y Ozeki Y Okamoto K Sagae T Someya T
author_facet	Sugawara N Yasui-Furukori N Yamazaki M Shimoda K Mori T Sugai T Matsuda H Suzuki Y Minami Y Ozeki Y Okamoto K Sagae T Someya T
author_sort	Sugawara N
title	Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
title_short	Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
title_full	Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
title_fullStr	Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
title_full_unstemmed	Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
title_sort	attitudes toward metabolic adverse events among patients with schizophrenia in japan
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/b06bc01b788d4341b317ed94c57eec5c
work_keys_str_mv	AT sugawaran attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT yasuifurukorin attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT yamazakim attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT shimodak attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT morit attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT sugait attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT matsudah attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT suzukiy attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT minamiy attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT ozekiy attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT okamotok attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT sagaet attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan AT someyat attitudestowardmetabolicadverseeventsamongpatientswithschizophreniainjapan
_version_	1718401144610357248

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan

Ejemplares similares